Ligand validation:6AJ5

ORO: OROTIC ACID

ORO is a Ligand Of Interest in 6AJ5 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6AJ5_ORO_B_502	60%	23%	0.137	0.922	1.21	1.93	1	4	0	0	100%	1
6AJ5_ORO_A_502	58%	21%	0.154	0.933	1.4	1.92	2	2	1	0	100%	1
6AJ5_ORO_D_502	48%	13%	0.195	0.938	1.14	2.82	-	5	0	0	100%	1
6AJ5_ORO_C_502	45%	16%	0.193	0.924	1.25	2.39	1	4	0	0	100%	1
6AJE_ORO_C_502	75%	14%	0.138	0.971	1.16	2.65	-	3	0	0	100%	1
9DHH_ORO_A_402	100%	8%	0.025	0.992	1.58	3.05	2	2	0	0	100%	1
6FMD_ORO_A_411	100%	9%	0.034	0.992	1.02	3.42	1	2	0	0	100%	1
9DHI_ORO_A_402	100%	0%	0.032	0.99	2.36	6.63	2	4	0	0	100%	1
9DHJ_ORO_A_402	100%	1%	0.033	0.989	2.35	6.35	2	4	0	0	100%	1
5H73_ORO_A_403	100%	5%	0.035	0.989	2.56	2.79	5	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.